Targeting m<sup>6</sup>A RNA Modification in Tumor Therapeutics
The prevalent eukaryotic RNA modification N6-methyladenosine (m<sup>6</sup>A), which is distributed in more than 50% of cases, has demonstrated significant implications in both normal development and disease progression, particularly in the context of cancer. This review aims to discuss...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Current Oncology |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1718-7729/32/3/159 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|